New shot shows promise for teen asthma
NCT ID NCT06786455
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single injection of a new drug called SHR-1905 in 9 teenagers with asthma. The goal was to see how the drug moves through the body, if it is safe, and if it helps control asthma. Participants were aged 12 to 17, had asthma for at least 6 months, and were on stable maintenance therapy. The study measured drug levels, side effects, and changes in breathing and inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI and a smartphone app may let kids with asthma skip clinic visits
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Short steroid course after first wheeze may stop asthma before it starts
- New antibody drug aims to tame Hard-to-Control asthma
- New asthma drug aims to improve breathing without daily pills
- Scientists compare two formulations of a potential asthma treatment